Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-16-006486

EVP AND GC sold 16,000 shares at an average $35.00 ($560,033)

  • EVP AND GC acquired 16,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Baity Glenn EVP AND GC 2016-07-11 Option exercise +4,057 $6.78 $27,506 66,978 D
Baity Glenn EVP AND GC 2016-07-11 Sale −4,057 $35.00 $142,001 62,921 D
Baity Glenn EVP AND GC 2016-07-12 Option exercise +5,298 $6.78 $35,920 68,219 D
Baity Glenn EVP AND GC 2016-07-12 Option exercise +645 $6.78 $4,373 68,864 D
Baity Glenn EVP AND GC 2016-07-12 Option exercise +3,375 $6.78 $22,883 72,239 D
Baity Glenn EVP AND GC 2016-07-12 Option exercise +2,625 $6.78 $17,798 74,864 D
Baity Glenn EVP AND GC 2016-07-12 Sale −11,943 $35.00 $418,031 62,921 D
Derivatives
Baity Glenn EVP AND GC 2016-07-11 Option exercise · Stock Option (right to buy) −4,057 5,298 D
Baity Glenn EVP AND GC 2016-07-12 Option exercise · Stock Option (right to buy) −5,298 0 D
Baity Glenn EVP AND GC 2016-07-12 Option exercise · Stock Option (right to buy) −645 0 D
Baity Glenn EVP AND GC 2016-07-12 Option exercise · Stock Option (right to buy) −3,375 0 D
Baity Glenn EVP AND GC 2016-07-12 Option exercise · Stock Option (right to buy) −2,625 0 D
Open-market sales · 16,000 sh · avg $35.00 · $560,033
Loading xslF345X03/form4-07132016_030713.xml…